Allergan Breast Implant Lawyer

After a BIA-ALCL Diagnosis, an Allergan Breast Implant Attorney Can Help You Fight Back

When a cancer diagnosis is caused by a product and procedure you trusted to be safe, you need an experienced BIA-ALCL attorney in your corner. If you or a loved one has been diagnosed with breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) after receiving Allergan's BIOCELL textured breast implants or tissue expanders, you may have legal options that go far beyond anything Allergan's 2019 recall warranty offered. At Spotlight Justice, Dena Young, an Allergan breast implant lawyer, is ready to help you understand what you may be owed and how to pursue it.

What sets Dena apart in this litigation is not just her deep experience handling mass tort litigation. She was among the first attorneys in the country to advocate for Allergan BIA-ALCL victims, bringing those cases and fighting for victims at a time when most law firms had not yet taken notice or declined these cases due to legal hurdles.

Attorney Dena Young brings a high level of case knowledge and institutional familiarity in this area of litigation. Our firm represents victims harmed by Allergan’s BIOCELL breast implants at no upfront cost, and every case begins with a free consultation with Dena herself. Contact us today for a no-cost, no-pressure evaluation of your potential case.

Your Path to Pursuing Justice Through an Allergan Breast Implant Lawsuit

Allergan BIA-ALCL claims are being pursued through a multidistrict litigation (MDL) consolidated before Judge Brian Martinotti in the U.S. District Court for the District of New Jersey, captioned In re: Allergan BIOCELL Textured Breast Implant Products Liability Litigation, MDL No. 2921.

With over 1,400 cases already on the docket and the first bellwether trial scheduled for October 19, 2026, the litigation is at a pivotal stage. New cases are still being accepted and new diagnoses are still being made.

If you were diagnosed with BIA-ALCL from Allergan’s BIOCELL breast implants, you may have grounds to file your own individual claim.

You may qualify for an Allergan BIOCELL lawsuit if:

• You received Allergan BIOCELL textured breast implants or tissue expanders, including any Natrelle brand products
• You were diagnosed with breast implant-associated anaplastic large cell lymphoma or another cancer in the scar tissue or fluid surrounding your implant
• You were not fully compensated by Allergan's recall warranty for your medical costs, explantation surgery, reconstruction, or ongoing monitoring
• You have not previously filed a lawsuit related to your BIA-ALCL diagnosis

Every state has its own statutes of limitations that set firm deadlines for filing personal injury claims. Those deadlines depend on when your diagnosis was made and when you reasonably discovered its connection to your implants. It is very important you protect your right to file before that window closes by consulting an Allergan breast implant attorney.

The BIOCELL Implants Behind the Allergan Recall and Lawsuits

Understanding what these devices are, how they came to be recalled, and why they gave rise to one of the most significant medical device litigations in recent years can help you make sense of your own situation. From there, you’re ready to discuss your potential case with an Allergan breast implant lawyer.

What to Know About Allergan's BIOCELL Textured Breast Implants

Allergan's BIOCELL textured breast implants and tissue expanders were used in both cosmetic augmentation and reconstructive breast surgeries for decades.

Unlike smooth implants, BIOCELL products featured a roughened surface created through a "salt-loss" manufacturing process. This textured surface was originally believed to improve tissue adherence and reduce implant movement.

These devices were sold under several Natrelle brand names, including:

• The Natrelle 410 line
• The Natrelle INSPIRA line
• The Natrelle Saline line

Allergan's predecessor subsidiary McGhan also manufactured certain affected products under earlier brand names.

If you are unsure whether your implants are BIOCELL devices, your plastic surgeon's records or the paperwork you received at the time of surgery should identify the specific model used in your procedure.

The 2019 FDA Recall of Allergan BIOCELL Breast Implants

In July 2019, the U.S. Food & Drug Administration requested that Allergan voluntarily recall all BIOCELL textured breast implants and tissue expanders from the global market. This request followed evidence identifying a disproportionate cancer risk.

At the time of the recall, 573 BIA-ALCL cases had been recorded worldwide. Of those, 481 involved Allergan implants, and 33 patients had died. The FDA's analysis found that Allergan's BIOCELL products carried a BIA-ALCL risk six times higher than any other textured implant on the market.

Allergan complied the same day the FDA issued its request. In May 2020, Allergan was acquired by AbbVie, Inc., which assumed all assets and liabilities related to the recalled products. The defendants in MDL 2921 are named as Allergan plc (now AbbVie, Inc.), Allergan, Inc., and Allergan USA, Inc.

What BIA-ALCL Is and Why It Matters to Your Case

BIA-ALCL is the central injury in Allergan breast implant litigation. Understanding what this injury is, and what it is not, can help you recognize whether your diagnosis may be connected to the implants you received.

How BIA-ALCL Develops

While Allergan breast implants have been linked to cancer, it’s important for patients to understand the details. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a form of non-Hodgkin lymphoma. It is not breast cancer.

Rather than originating in breast tissue, as breast cancer does, BIA-ALCL develops in the scar tissue or fluid that surrounds a breast implant.

Most cases come to light when a patient notices unusual swelling, fluid buildup, or a mass near the implant. These signs can sometimes develop years after the original surgery. In fact, in the ongoing Allergan breast implant litigation, plaintiffs have seen BIA-ALCL symptoms develop anywhere from six months to more than two decades after implantation.

Women who received BIOCELL implants in the 1990s and 2000s are still receiving new diagnoses today.

Your prognosis after being diagnosed with BIA-ALCL depends on specific facts. Some cases respond well to surgical treatment, but not all cases do. Advanced BIA-ALCL can spread to the lymph nodes and other organs. Multiple deaths have been attributed to this disease.

At Spotlight Justice, we fight to secure compensation that makes cancer survivors as whole as possible while also pursuing accountability and meaningful recoveries for the grieving families of patients who lost their lives to BIA-ALCL.

Symptoms That Should Prompt Immediate Medical Evaluation

As scary as the possibility of a cancer diagnosis may be, the reality is that early detection can contribute to better outcomes. If you have or had Allergan BIOCELL implants and notice any of the following symptoms, contact your physician promptly.

• Sudden or persistent swelling near the implant, particularly if it develops years after surgery
• A lump, hardening, or mass in the tissue surrounding the implant
• Pain or tenderness near the breast or armpit
• Redness or a skin rash near the implant
• Enlarged lymph nodes in the armpit, neck, or chest
• Unexplained fever, fatigue, or unintended weight loss

Your health should be your first priority, but preserving your legal rights is also crucial. A claim can provide the resources you need to treat your cancer and address both financial costs, like lost income, and the non-economic impacts of your illness. Reach out to Attorney Dena Young, an Allergan breast implant lawyer, to understand your legal options.

What Allergan Breast Implant Lawsuits Allege

The claims consolidated in MDL 2921 center on allegations that Allergan was aware of the link between BIOCELL implants and BIA-ALCL well before the 2019 recall, and that the company failed to take adequate action to protect the women who received its products.

The core allegations include:

• Failure to warn: Allergan did not disclose the BIA-ALCL risk in the prescribing information and package insert provided with its implants, even as adverse event reports and clinical data continued to accumulate.
• Manufacturing defects: Plaintiffs allege that silicone debris and particulate matter on the BIOCELL textured surface contributed to chronic inflammation around the implant, increasing cancer risk. These defects, plaintiffs argue, were not part of the intended design and represented departures from Good Manufacturing Practices.
• Failure to report: Allergan allegedly did not properly comply with its FDA post-market surveillance obligations, delaying the disclosure of safety signals that warranted earlier action.
• Misleading marketing: The company promoted BIOCELL implants based on aesthetic and functional advantages without disclosing the elevated cancer risk that distinguished them from other products on the market.

As of February 2021, Judge Martinotti ruled that many of the plaintiffs' core claims could proceed past Allergan's motions to dismiss. This included claims related to manufacturing defects. For plaintiffs, this ruling provided the opportunity to pursue meaningful compensation.

The Compensation You May Be Able to Recover in an Allergen Breast Implant Lawsuit

A BIA-ALCL diagnosis carries costs and consequences that extend far beyond initial treatment. Your cancer battle can affect your ability to work, your financial stability, your relationships, and your long-term health. At Spotlight Justice, we seek to recover compensation for all of our clients’ legally recognizable losses.

The recoverable damages in your Allergan breast implant lawsuit may include:

• Past and future medical expenses, such as explantation (implant removal) surgery, cancer treatment, reconstruction, and long-term monitoring
• Lost income and diminished earning capacity resulting from illness and treatment
• The out-of-pocket costs of diagnosis and surgery not covered by Allergan's warranty
• Physical pain and suffering
• Emotional distress
• Loss of quality of life due to illness or medical interventions
• Wrongful death damages, for families who have lost a loved one to BIA-ALCL

No specific outcome can be promised in individual circumstances. Every case must be evaluated based on its own facts. But we believe that you deserve to know what compensation may be available before you decide whether to file. Speaking with our Allergan breast implant attorney, Dena Young, allows you to get a candid, no-pressure assessment of your options and what losses you may be able to receive compensation for.

An Allergan Breast Implant Lawyer With Insight That Goes Beyond the Filing

Most firms handling Allergan BIA-ALCL cases today are large national mass tort operations that joined this litigation years after it began. They bring volume, but large caseloads aren’t always in a client’s best interests. What sets Spotlight Justice and our low-volume, high-attention model apart is our commitment to providing the personalized service that a serious cancer case demands and our depth of institutional knowledge that comes from having been in this fight from the very beginning.

Dena Young was among the first attorneys in the country to take on cases for Allergan BIA-ALCL victims. She brought those early cases at a time when most law firms were not yet paying attention or intimidated by the legal hurdles. In doing so, she built an in-depth understanding of the medical and legal dimensions of this litigation from the ground up. That early involvement gave her direct insight into how the foundational arguments were constructed, how the key legal theories were tested, and how courts and opposing counsel engaged with those claims in the litigation's formative stages.

At Spotlight Justice, we provide the caliber of mass tort experience typically found only at national firms, paired with the kind of direct attorney access and personal attention that can be more difficult to maintain at larger firms. We intentionally limit our caseload so clients have direct access to Dena throughout their case. Dena is prepared to travel to meet you at home or at the hospital if needed, because we know that clients facing a cancer diagnosis should not have any additional obstacles to overcome.

Take the First Step With a Free Consultation

The litigation is progressing toward resolution. If you have been diagnosed with BIA-ALCL after receiving Allergan BIOCELL implants, the time to evaluate your options is now.

Spotlight Justice is currently accepting diagnosed BIA-ALCL cases nationwide. As your Allergan breast implant lawyer, Dena Young will personally review your case, answer your questions directly, and help you understand whether filing a claim is the right step for you. We’re here to empower you to make informed decisions, and there’s no pressure, no obligation, and no upfront cost.

At Spotlight Justice, we handle Allergan BIA-ALCL cases on a contingency fee basis. You pay nothing unless we recover compensation for you, and taking legal action won’t add to your hardships.

You deserve individualized attention from a compassionate advocate who genuinely cares about your struggles, your family, and your future. Get in touch with Spotlight Justice today by phone or through our online contact form to schedule your free consultation with Dena Young, an Allergan breast implant attorney who is ready to stand behind your case from the very first conversation.